- Abigail Coursolle
- Alejandra Pavisich
- Alejandra Pavisich
- Alexis Robles-Fradet
- Alicia Emanuel
- Amanda Avery
- Amy Chen
- Andy DiAntonio
- Arielle Linsey
- Brian Brooks
- Candace Gibson
- Carly Myers
- Cassandra LaRose
- Cat Duffy
- Catherine McKee
- Cathren Cohen
- Charlie Blodnieks
- Charly Gilfoil
- Cheyenne Peters
- Christina Piecora
- Corey Davis
- Dania Douglas
- Daniel Young
- David Machledt
- Deanna Hartog
- Elizabeth Edwards
- Elizabeth G. Taylor
- Emma Parker-Newton
- Eskedar Girmash
- Fabiola De Liban
- Georgesula Ziama
- Geron Gadd
- Hannah Eichner
- Hayley Penan
- Héctor Hernández-Delgado
- Ian McDonald
- Jane Perkins
- Jasmine Young
- Jennifer Lav
- Joe McLean
- Jules Lutaba
- Kally Xu
- Kasey Nichols
- Kavisha Prajapati
- Kimberly Lewis
- Leonardo Cuello
- lhigashi
- Liz McCaman Taylor
- Madeline Morcelle
- Mara Youdelman
- Margaret Okakpu
- Maya Levin
- Michelle Lilienfeld
- Michelle Yiu
- Miriam Delaney Heard
- Mizue Suito
- Priscilla Huang
- Rachel Holtzman
- Rolonda Donelson
- Sarah Grusin
- Sarah Somers
- Skyler Rosellini
- Susan Berke Fogel
- T. Nancy Lam
- veng
- Walter Hsiang, MD
- Wayne Turner
- Zamir M. Brown
- Show all
- Alabama
- Alaska
- All United States
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- National
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
- Show all
- 1557
- 50th Anniversary
- Abortion
- Admin and Procedural Barriers
- ADS Evergreen
- Affordable Care Act
- Assisted Reproduction
- Automated Decision Making
- Behavioral Health
- Child and Adolescent Health
- CHIP
- Civil Procedure
- Civil Rights
- Coronavirus
- Cost-sharing
- Court Access
- COVID-19 Public Health Emergency
- Data Collection
- Defending Medicaid
- Delivery System Featured
- Delivery System Reform
- Demonstrations
- Disability
- Disability Rights
- Doula Care
- Dual Eligible Beneficiaries
- Eligibility and Enrollment
- EPSDT
- Exchanges/Marketplaces
- Family Planning
- Federal and State Court Cases
- Foster youth
- HCBS/LTSS
- Health Care Reform
- Health Care Refusals
- Health Disparities
- Health Reform
- HIV/AIDS and Sexual Health
- Home and Community Based Services
- Immigrant Health
- Language Access
- LGBTQ Health
- Litigation
- Managed Care
- Medi-Cal
- Medicaid
- Medicaid Awareness Month
- Medicaid Awareness Month 2024
- Medicaid Defense 2025
- Mental Health
- Nondiscrimination
- Opioid Use Disorder
- Oral Health
- Pregnancy
- Prescription Drugs Marketplace
- Prescription Drugs Medicaid
- Privacy and Confidentiality
- Protect Medicaid 2023
- Public Charge
- Public Health
- Refusals of SRH Care
- Reproductive Health
- Services
- Sexual and Reproductive Health (SRH)
- Sexual Health
- SRH Equity
- SRH Equity for Immigrants
- SRH Equity for LGBTQI+ People
- SRH Equity for People of Color
- SRH Equity for People with Disabilities
- SRH Equity for Young People
- SRH Nondiscrimination
- Supreme Court
- Telehealth
- Waivers and Demonstrations
- Women's Health
- June 13, 2022
Health Care Refusals & How They Undermine Standards of Care Part II: The Impact of Health Care Refusals, Discrimination, and Mistreatment on LGBTQ Patients and Families
Read more*Co-authored with Hayley Penan*This is Part II of the National Health Law Program’s two part blog series on the topic of health care refusals and how they undermine standards of care. Part I of the blog series was a very topline review of the topics covered in the original…
- June 13, 2022
Health Care Refusals & How They Undermine Standards of Care Part I: An Overview
Read moreCo-authored with Hayley Penan*In July 2013, Susan Berke Fogel, then Director of the National Health Law Program’s Reproductive and Sexual Health Team, published Health Care Refusals: Undermining Quality Care for Women. This report detailed how health care refusals and denials of care rooted in political ideology, or institutional or…
- June 6, 2022
NHeLP Comments on Healthy Louisiana Substance Use Disorder 1115 Demonstration Extension Request
Hector Hernandez-Delgado CommentsRead moreIn comments to HHS, NHeLP urges the Secretary to reject Louisiana's Section 1115 demonstration extension request to continue waiving the Institutions for Mental Diseases (IMD) exclusion. This letter emphasizes that while NHeLP is supportive of efforts to increase access to services for Medicaid beneficiaries with substance use disorders (SUD),…
- May 27, 2022
California’s Historic Medi-Cal Exclusion Removal for Older Adults Regardless of Immigration Status
Alicia Emanuel and Iván Barragan* california, Eligibility & Enrollment, UncategorizedRead more*Co-authored with Iván Barragan, CA Immigrant Policy CenterAs of May 1, 2022, California removed the exclusion to full-scope Medi-Cal for all income-eligible adults ages 50 and older, regardless of immigration status. At least 244,000 Californians have already been enrolled and benefited from this historic “Older Adult” victory. This advancement…
- May 5, 2022
NHeLP Comments on Pennsylvania SUD Demonstration Extension
Read moreIn comments to HHS, NHeLP urges the Secretary to reject Pennsylvania's Section 1115 demonstration extension request to continue waiving the Institutions for Mental Diseases (IMD) exclusion. This letter emphasizes that while NHeLP is supportive of efforts to increase access to services for Medicaid beneficiaries with substance use disorders (SUD),…
- April 8, 2022
More Transparency Needed to Ensure Medicaid Beneficiaries Have Access to Necessary Off-Label Prescription Drugs
Read moreUnder federal law, state Medicaid programs are required to cover (with a few exceptions) outpatient prescription drugs for “medically accepted indications.” Medically accepted indications are both those that are included on the drug’s label by the FDA as part of the approval process, and certain “off-label” uses.Medicaid programs are…
